Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Bria-OTS by BriaCell Therapeutics for Metastatic Breast Cancer: Likelihood of Approval
Bria-OTS is under clinical development by BriaCell Therapeutics and currently in Phase II for Metastatic Breast Cancer. According to GlobalData,...
Data Insights
Risk adjusted net present value: What is the current valuation of BriaCell Therapeutics's BriaVax?
BriaVax is a gene-modified cell therapy commercialized by BriaCell Therapeutics, with a leading Phase III program in Metastatic Breast Cancer....